Dyne Therapeutics to Present at Upcoming Investor Conferences
Dyne Therapeutics (Nasdaq: DYN), a clinical-stage muscle disease company, has announced its participation in three major upcoming investor conferences. The company will participate in fireside chats at the Guggenheim Inaugural Healthcare Innovation Conference on November 13 in Boston, the Stifel 2024 Healthcare Conference on November 19 in New York, and the Piper Sandler 36th Annual Healthcare Conference on December 3 in New York. Live webcasts of all presentations will be available on Dyne's website, with replays accessible for 90 days.
Dyne Therapeutics (Nasdaq: DYN), un'azienda in fase clinica che si occupa di malattie muscolari, ha annunciato la sua partecipazione a tre importanti conferenze per investitori in arrivo. L'azienda parteciperà a discussioni informali durante la Guggenheim Inaugural Healthcare Innovation Conference il 13 novembre a Boston, la Stifel 2024 Healthcare Conference il 19 novembre a New York e la Piper Sandler 36th Annual Healthcare Conference il 3 dicembre a New York. Le dirette delle presentazioni saranno disponibili sul sito web di Dyne, con le registrazioni accessibili per 90 giorni.
Dyne Therapeutics (Nasdaq: DYN), una empresa en etapa clínica dedicada a enfermedades musculares, ha anunciado su participación en tres importantes conferencias para inversores que se acercan. La compañía participará en charlas informales en la Guggenheim Inaugural Healthcare Innovation Conference el 13 de noviembre en Boston, en la Stifel 2024 Healthcare Conference el 19 de noviembre en Nueva York y en la Piper Sandler 36th Annual Healthcare Conference el 3 de diciembre en Nueva York. Las transmisiones en vivo de todas las presentaciones estarán disponibles en el sitio web de Dyne, con repeticiones accesibles durante 90 días.
Dyne Therapeutics (나스닥: DYN)은 임상 단계의 근육 질환 회사로, 다가오는 주요 투자자 회의 3곳에 참여한다고 발표했습니다. 이 회사는 11월 13일 보스턴에서 열리는 구겐하임 첫 번째 헬스케어 혁신 회의, 11월 19일 뉴욕에서 열리는 스티펠 2024 헬스케어 회의, 그리고 12월 3일 뉴욕에서 열리는 파이퍼 샌들러 제36회 연례 헬스케어 회의에서 파이어사이드 챗에 참여할 예정입니다. Dyne의 웹사이트에서는 모든 발표의 실시간 웹캐스트를 제공하며, 재생은 90일 동안 가능합니다.
Dyne Therapeutics (Nasdaq: DYN), une entreprise en phase clinique spécialisée dans les maladies musculaires, a annoncé sa participation à trois grandes conférences pour investisseurs à venir. L'entreprise participera à des discussions informelles lors de la Guggenheim Inaugural Healthcare Innovation Conference le 13 novembre à Boston, de la Stifel 2024 Healthcare Conference le 19 novembre à New York et de la Piper Sandler 36th Annual Healthcare Conference le 3 décembre à New York. Les diffusions en direct de toutes les présentations seront disponibles sur le site web de Dyne, avec des rediffusions accessibles pendant 90 jours.
Dyne Therapeutics (Nasdaq: DYN), ein in der klinischen Phase befindliches Unternehmen für Muskelerkrankungen, hat seine Teilnahme an drei großen bevorstehenden Investorenkonferenzen bekannt gegeben. Das Unternehmen wird an informellen Gesprächen bei der Guggenheim Inaugural Healthcare Innovation Conference am 13. November in Boston, der Stifel 2024 Healthcare Conference am 19. November in New York und der Piper Sandler 36th Annual Healthcare Conference am 3. Dezember in New York teilnehmen. Live-Streaming der Präsentationen wird auf Dyne's Website verfügbar sein, mit Rückblicken, die für 90 Tage zugänglich sind.
- None.
- None.
WALTHAM, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that management is scheduled to present at the following upcoming investor conferences:
- Guggenheim Inaugural Healthcare Innovation Conference, fireside chat on Wednesday, November 13, 2024 at 4:00 p.m. ET in Boston
- Stifel 2024 Healthcare Conference, fireside chat on Tuesday, November 19, 2024 at 3:00 p.m. ET in New York
- Piper Sandler 36th Annual Healthcare Conference, fireside chat on Tuesday, December 3, 2024 at 3:00 p.m. ET in New York
A live webcast of each presentation will be available in the Investors & Media section of Dyne’s website at https://investors.dyne-tx.com/news-and-events/events-and-presentations and a replay will be accessible for 90 days.
About Dyne Therapeutics
Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue. Dyne has a broad pipeline for serious muscle diseases, including clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD) and a preclinical program for facioscapulohumeral muscular dystrophy (FSHD). For more information, please visit https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.
Contact:
Amy Reilly
areilly@dyne-tx.com
857-341-1203
FAQ
What investor conferences will Dyne Therapeutics (DYN) attend in late 2024?
Where can I watch Dyne Therapeutics (DYN) investor conference presentations?
What type of presentations will Dyne Therapeutics (DYN) give at the 2024 healthcare conferences?
Which cities will host Dyne Therapeutics (DYN) investor presentations in late 2024?
